1.25 semaglutide Getting started on GLP-1 medications The FDA approved a pill
Description
With bariatric surgery, patients can lose up to 60% of their excess weight within 6 months of the procedure and 77% within 12 months post-op
As soon as January 2026, companies like Sandoz and Apotex are expected to launch generic versions of semaglutide in Canada, where protections from data exclusivity will come to an end
Erica Oberg's telehealth GLP-1 Treatments, Semaglutide or Tirzepatide medical weight loss program in San Diego, CA starts to make a lot of sense
Uncomfortable withdrawal side effects can also drive a patient back to using a substance to make the symptoms go away
